Verona Pharma's total assets for Q4 2024 were $474.24M, an increase of 24.21% from the previous quarter. VRNA total liabilities were $269.68M for the fiscal quarter, a 7.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.